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Experimental disease models have enhanced our understand-
ing of the pathogenesis of atherosclerosis development. For
example, insight has been gained into the role of the
endothelium, lipids, platelets and inflammation, as well as
into potential diagnostic and therapeutic interventions. More-
over, transgenic and knock-out technologies have become a
widespread approach and this is a growing field to assess the
role of individual genes in vascular biology and pathology.
However, atherosclerosis is most of all a multifactorial
disease, influenced by a multitude of environmental factors.
Therefore, it is important to also study non-transgenic animal
models that closely resemble the human situation with
atherosclerotic lesions at anatomical locations that mimic the
clinical manifestation of the disease, e.g. coronary artery
disease (CAD). Although no model completely mimics
human atherosclerosis, much can be learned from existing
models in the study of this disease, also with respect to the
development of new interventions. Here, we describe the most
relevant animal models of atherosclerosis, while focusing on
CAD development and the use of coronary diagnostic and
therapeutic interventions. In addition, we show examples of
features of a large animal model of CAD including pictures of
invasive coronary imaging.
Small versus large animal models
Small animal models, primarily small rodents and rabbits,
have been used extensively in atherosclerosis research.
Some of the reasons include low costs, availability, and
easy usability (Table 1). However, mice do not spontane-
ously develop atherosclerosis without genetic manipulation
since they have a lipid profile that is different from humans.
Yet, due to genetic modification and cross-breeding specific
strains can be generated and used to unravel molecular
mechanisms involved in the atherosclerosis process [1].
However transgenic mouse models do not typically develop
advanced lesions, including plaque rupture and thrombosis
[2], which is typical in patients presenting with symptom-
atic disease. When size becomes more important, small
animal models need to be complemented by larger animal
models in which vessel characteristics are more similar to
human arteries. The rabbit model on a high cholesterol diet
has been widely used in the study of experimental
atherosclerosis (Table 1). Combined with arterial wall
injury, lesions at least partly resembling human plaque
will develop in the aorta or iliac arteries of this model
[3]. However, when coronary atherosclerosis is the object
of study, pigs seem to be the most representative model
(Table 1). Pigs have a highly similar anatomy and
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physiology of the coronary system as compared to humans
[4]. In addition, with use of toxin-mediated pancreatic
damage and a high fat diet, human diabetes mellitus
(DM)-like metabolic alterations will develop [5], followed
by coronary lesions resembling the human condition
closely with even some characteristics of vulnerable
plaque [6, 7]. Historically monkeys have also been
considered to be a good model of human atherosclerosis
(Table 1); in particular the effects of hormones and the role
of behaviour can be studied with this model [8, 9].
However, nowadays monkeys are not widely used due to
obvious species-specific ethical concerns and costs [2].
In the validation process of coronary interventional
devices and therapies for diagnosis and treatment of
human CAD, both healthy rabbit [10] and pig models
[11] have been used extensively, although the rat model
has also been used occasionally [12] (Table 1). In these
models, arterial overstretch injury with stenting will result
in a restenosis process with re-endothelialisation, inflam-
mation and neointima formation. However, these are
healthy animal models in which the vascular healing
response occurs faster than in diseased humans [10, 11].
Therefore, the USA Food and Drug Administration has
proposed a guidance that new coronary diagnostic and
therapeutic interventional devices need to be tested in
more clinically relevant animal models of disease
(6255companion.doc, 2008). Since the porcine model is
Table 1 Animal models of atherosclerosis
Animal model Advantages Limitations
Mouse 1 Rapid development of atherosclerotic plaque 1 Limited resemblance to humans
2 Short reproductive cycle+large litters 2 Limited complex atherosclerotic lesion formation
3 Well-known genome+genome manipulation possible 3 Very high levels of blood lipids+different lipid profile
4 Cheap
Rat 1 Useful as restenosis model 1 No development of atherosclerotic lesions
2 Cheap
Rabbit 1 Fibroatheroma lesions 1 Need for high plasma cholesterol levels to develop atherosclerosis
2 Useful as restenosis model 2 No plaque rupture model
3 Affordable 3 Model for neointima formation+re-endothelialisation rather than
atherosclerosis
4 Coronary evaluation difficult
Pig 1 Atherosclerotic lesions similar to human disease 1 Expensive
2 Blood lipids in human range 2 Difficult to handle due to size
3 Invasive coronary imaging possible 3 Limited genomic tools
4 Useful as restenosis model post-intervention
5 Useful for detailed coronary endothelial function studies
Monkey 1 Atherosclerotic lesions similar to human disease 1 Ethical concerns
2 Influence of behavioural factors, e.g. psychosocial
stress
2 Very expensive
3 Influence of hormonal status 3 Difficult to handle
Table 2 Plasma characteristics
Plasma markers Diabetic pigs Non-diabetic
pigs
Two-way
ANOVA
Glucose (mmol/l) P<0.01a
9 months 15±2.9* 4.1±0.27
12 months 13±2.3* 4.5±0.47
15 months 18±4.5* 5.1±0.42
Triglycerides (mmol/l) P=0.02a
9 months 1.15±0.26 0.64±0.27
12 months 0.95±0.25 0.44±0.08
15 months 1.26±0.50 0.64±0.19
Cholesterol (mmol/l) P=0.86
9 months 20±2.0 20±2.6
12 months 18±1.8 19±2.0
15 months 17±1.7 18±2.7
LDL cholesterol (mmol/l) P=0.75
9 months 17±1.9 16±2.2
12 months 15±1.6 15±1.9
15 months 14±1.7 15±2.5
HDL cholesterol (mmol/l) P=0.13
9 months 5.2±0.22 5.8±0.21
12 months 5.7±0.31 5.7±0.31
15 months 5.1±0.40 5.7±0.35
Values are mean±SEM,
*P<0.05 diabetic vs. non-diabetic pigs at corresponding time points,
a diabetic vs. non-diabetic pigs over time
LDL low density lipoprotein, HDL high density lipoprotein
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the only model in which CAD can be truly studied and
catheters and coronary interventional devices can be
applied to the vascular bed they are designed for, this
model might be considered the most suitable [13]. New
types of invasive coronary imaging techniques have
already been applied in the pig model, e.g. optical
coherence tomography (OCT) in healthy porcine coronar-
ies [14] and intravascular ultrasound (IVUS) in diseased
porcine coronaries [7].
Present animal model
In light of the considerations outlined above, the present study
was undertaken to investigate coronary atherosclerosis devel-
opment over time with the use of a diseased porcine model.
The study was performed in accordance with the Guide for the
Care and Use of Laboratory Animals (NIH Publication No.
85-23, revised 1996), and with approval of the Erasmus MC
Animal Care committee. For this purpose, diabetes was
induced in a subgroup of male crossbred (Yorkshire x
Landrace) pigs by single dose injection of streptozotocin
(140 mg/kg) to give a subtotal destruction of pancreatic beta-
cells, as described previously [5]. After 2 weeks of stable DM
induction, a high fat atherogenic diet was introduced to all
pigs. The pigs (diabetic: n=8; non-diabetic: n=7) were
adjusted to this diet and followed up to study atherosclerosis
development over time up to 15 months. Similar growth
patterns were achieved in all pigs via adjustment of
individual caloric intake. Moreover, blood glucose levels
were monitored in diabetic pigs and insulin therapy was
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Fig. 1 Typical example of the
development of an atherosclerotic
plaque over time on OCT and
IVUS in a diabetic pig; a OCT of
intimal hyperplasia at 9 months
(*); b IVUS of the same cross
section as shown in a fails to
clearly detect the early lesion;
c+d OCT and IVUS of the
growing plaque at 12 months (*);
e+f OCT and IVUS of the same
growing plaque at 15 months (*)
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started only when plasma ketones appeared, to prevent
severe DM-related complications. Anaesthetised pigs were
imaged at 9, 12 and 15 months of study duration by two
invasive coronary imaging modalities. Moreover, arterial
blood samples were taken at these time points. A subgroup
of pigs (n=5) was sacrificed at 12 months, the remaining
animals (n=10) at 15 months to obtain coronary tissue for
histology. Afterwards, plasma concentrations of glucose,
total cholesterol, and low and high density lipoprotein
(LDL and HDL) cholesterol were measured at the clinical
chemical laboratory of the Erasmus MC using standard
protocols.
Imaging modalities
Two invasive coronary imaging modalities were used in the
present study: OCT and gray-scale IVUS. OCT, using an
infrared light source, has an imaging depth of approximately
1.5 mm into tissue, an axial resolution of 10–15 μm and a
lateral resolution of 25–40 μm. This image resolution of
OCT offers the potential to assess coronary atherosclerosis
in detail [15, 16]. Evaluation of atherosclerosis by OCT was
performed in vivo in all pigs at 9, 12 and 15 months using
the C7 XR Fourier-Domain OCT system (St. Jude Medical,
Westford, MA, USA). Cross-sectional images were acquired
at 100 frames per second with an automatic pullback speed
of 20 mm/s.
The limited penetration depth of OCT is a shortcom-
ing for the assessment of the total vessel wall, particu-
larly in case of a diseased vessel. Therefore, in case of a
plaque thickness >1.5 mm, evaluation of the plaque was
done by gray-scale IVUS using an automated pullback
speed of 0.5 mm/s (Atlantis SR Pro, Boston Scientific
Corp., Natick, MA, USA). During pullback acquisition,
images were obtained at a rate of 30 frames/s. This technique,
using sound instead of light, has an axial resolution of 80–
200 μm and a lateral resolution of 200–400 μm. The
penetration depth is 4–8 mm, which permits visualisation
of the total vessel wall and therefore precise assessment of
the extent of atherosclerosis within a segment of a
coronary artery [17].
Preliminary results
In diabetic pigs, plasma glucose levels were elevated at
every measured time point as compared with the non-
diabetic pigs (Table 2, P<0.05). Moreover in this group
of pigs, plasma triglycerides were increased over time
(Table 2, P<0.05) as well. Since both groups were fed an
atherogenic diet, both showed elevated total cholesterol,
LDL and HDL levels, which were not different over time
(Table 2). In summary, diabetic pigs showed human-like DM
characteristics of hyperglycaemia and triglyceridaemia,
whereas all pigs showed evidence of hypercholesterolaemia.
These metabolic alterations were accompanied by
coronary atherosclerosis development. Indeed, at
9 months small early lesions could be detected in the
coronary arteries of most pigs, specifically seen with
OCT imaging (Fig. 1a). With IVUS this early stage of
atherosclerosis was not visible (Fig. 1b). Over time (12
and 15 months), these lesions showed progression, both in
size and in quantity as exemplified with OCT and IVUS
(Fig. 1c - f). Histology at 12 months confirmed the
formation of more complex coronary atherosclerosis at
this time point, consisting of lipid accumulation and
calcification also seen on IVUS (Fig. 2a - c). All pigs
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Fig. 2 Typical example of IVUS (a) and histology (b, c) of a
coronary atherosclerotic plaque in a diabetic pig. a IVUS of the same
plaque as seen in b and c with deep calcium (white arrow). b and c
show an overview and detail of the plaque with circumferential lipid
accumulation (stained red) and deep calcification (Ca, remaining rim
stained blue). The coronary plaque even shows the presence of a thin
fibrous cap (black arrow) overlying the superficial lipid-rich tissue,
showing a likeness to a thin cap fibrous atheroma [18]. Oil-red-O
stain, bar in b is 700 μm, bar in c is 200 μm
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were sacrificed at 15 months because of the attained
body weight and related handling difficulties (diabetic vs.
non-diabetic: 97±3 vs. 96±1 kg).
Conclusion
Different animal models are useful to study different
aspects in the process of atherosclerosis development
(Table 1). However, for the study of CAD and related
diagnostic and therapeutic interventions, a porcine disease
model seems most suitable. In the presence of several
metabolic alterations, lesions develop within 9 to 12 months,
closely resembling human coronary atherosclerotic plaques
upon examination by histology.
In addition, examples from this model show that OCT
and gray-scale IVUS appear to be highly complementary
imaging modalities for the evaluation of the development of
coronary atherosclerotic plaque over time. The present
preliminary results indicate that these modalities can be
used for plaque characterisation in vivo, making this large
diseased animal model ideal for studying new coronary
diagnostic and therapeutic interventions.
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